Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Media
Around the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsShortsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Dimitrios Bafaloukos, MD

Advertisement

Articles by Dimitrios Bafaloukos, MD

Paclitaxel and Carboplatin as First-Line Chemotherapy for Advanced Breast Cancer

ByGeorge Fountzilas, MD,Dimitrios Bafaloukos, MD,Gerasimos Aravantinos, MD,Constantine Nicolaides, MD,Haralambos Kalofonos, MD,Pavlos Papakostas, MD,Nicholaos Xiros, MD,Evalgelia Razi, MD
January 1st 1998

In a phase II study, 66 patients with advanced breast cancer (median age 56 years; range, 28 to 75 years) were treated with paclitaxel (Taxol), 175 mg/m² infused over 3 hours, and carboplatin (Paraplatin), dosed to attain an

Advertisement

Latest Updated Articles

  • Paclitaxel and Carboplatin as First-Line Chemotherapy for Advanced Breast Cancer
    Paclitaxel and Carboplatin as First-Line Chemotherapy for Advanced Breast Cancer

    January 1st 1998



Advertisement
Advertisement

Trending on CancerNetwork

1

FDA OKs Lutetium Lu 177 Vipivotide Tetraxetan in Metastatic Prostate Cancer

2

Teclistamab/Talquetamab Hits Record Low Hazard Ratio in Multiple Myeloma

3

TIL Cell Therapy in HIV Positive Patient With Metastatic Melanoma: Case Report

4

Gedatolisib/Fulvestrant Earns NCCN Category 1 Listing for HR+/HER2- Breast Cancer

5

Salt-Formulation Cabozantinib Capsules Receive FDA Tentative Approval in RCC, HCC, epNET

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us